Orders, handoffs and other people

Charting an off-label prescription so the reasoning shows

Off-label is legal. A chart that only says 'pt agrees' makes a careful decision look exactly like a lazy one.

8 min read built on 3 full opinions updated 2026-10-21

Written by a med-surg RN, ten years, day shift. Why there is no name on it · How this guide is made

Denise reacting to this topic
All sections

You're an NP and you picked a drug for a use that isn't on its label. That's legal, and it's common. What often goes missing is the chart: why this drug, what else you considered, and what the patient heard before saying yes. Leave those three out and a later reader can't tell a careful decision from a lazy one.

Key points

  • Name the indication in plain clinical terms. Say that this use is off label.
  • Write why this drug fits this patient: the evidence or guideline you used, plus the facts about this person.
  • List the on-label options you considered and why each one was out (tried and failed, contraindicated, not tolerated, patient declined).
  • Chart the consent conversation itself: off-label status, main risks, any boxed warning, alternatives (no treatment counts), the patient's questions, and the patient's answer in their own words.
  • Set a monitoring plan and a reassessment date. Then chart the follow-up.

What to write

How people write it How it reads better
Off-label use d/w pt, agrees.Prescribing gabapentin 300 mg qhs for vasomotor symptoms (off label; not FDA approved for this use). Pt informed this use is off label and what that means: drug is approved for other conditions; evidence for hot flashes comes from published trials, not FDA review.
Hormone therapy not appropriate.On-label options considered: systemic estrogen therapy ruled out due to hx of DVT 2023. Paroxetine 7.5 mg (on label for VMS) discussed; pt declined due to prior sexual side effects on SSRI.
Risks/benefits explained.Discussed: dizziness, sedation, fall risk at night, weight gain, need to taper rather than stop abruptly. Benefit: expected reduction in frequency of night sweats; response typically assessed over several weeks.
Pt understands.Pt restated in own words: it's a seizure/nerve pain drug used for hot flashes, may make me sleepy, don't stop suddenly. Pt asked whether it interacts with her BP meds; reviewed med list, no interaction identified.
Started quetiapine for sleep.Quetiapine 25 mg qhs for insomnia (off label). Chosen after failed trials of CBT-I (8 weeks) and trazodone 50 mg (morning sedation). Pt has comorbid bipolar II, already approved indication considered. Discussed metabolic risk and boxed warning; baseline A1c and lipids ordered.
F/u prn.Reassess in 4 weeks: symptom diary, BP, dizziness, falls. Pt to call clinic for oversedation, confusion, or rash.

The clinical details in this table are illustrative. Put in your own patient's facts and check doses against your references.

Template

Initial prescribing note (off-label section)

OFF-LABEL PRESCRIPTION
Date/time: [DATE] [TIME]
Drug/dose/route/frequency: [DRUG] [DOSE] [ROUTE] [FREQUENCY]
Indication: [CONDITION]. This use is off label (not an FDA-approved indication for this drug).

Rationale: [WHY THIS DRUG FOR THIS PATIENT: SYMPTOMS, SEVERITY, RELEVANT HISTORY].
Evidence relied on: [GUIDELINE / TRIAL / DRUG REFERENCE, WITH YEAR].
Warnings reviewed: [BOXED WARNING OR "NONE ON LABEL"], checked in [REFERENCE] on [DATE].

Alternatives considered:
- [ON-LABEL OPTION 1]: [TRIED: DOSE, DURATION, RESULT / CONTRAINDICATED: REASON / DECLINED: REASON]
- [ON-LABEL OPTION 2]: [SAME]
- Non-drug option: [WHAT, AND STATUS]
- No treatment: discussed; [PATIENT RESPONSE].

Consent discussion (with [PATIENT NAME]; also present: [NAMES/ROLES OR NONE]; interpreter: [NONE / NAME, ID, MODE]):
- Explained that this use is off label and what that means.
- Expected benefit: [BENEFIT AND TIMEFRAME].
- Risks discussed: [SPECIFIC RISKS], including [BOXED WARNING IF ANY].
- Alternatives above reviewed, including no treatment.
- Patient questions: [QUESTION 1] / answered: [ANSWER]. [QUESTION 2] / answered: [ANSWER].
- Patient restated in own words: [PATIENT'S SUMMARY].
- Decision: patient chose to [START / NOT START] [DRUG].
- Written material given: [HANDOUT / MED GUIDE / NONE].

Monitoring: [LABS / VITALS / SYMPTOM TRACKING]. Reassess on [DATE].
Patient to contact clinic for: [RED FLAG SYMPTOMS].
[NP NAME], [CREDENTIALS]

Follow-up or dose-change note

OFF-LABEL FOLLOW-UP
Date/time: [DATE] [TIME]
[DRUG] [CURRENT DOSE] for [CONDITION] (off label), started [START DATE].

Response: [SYMPTOM CHANGE WITH NUMBERS IF AVAILABLE].
Adverse effects: [NONE REPORTED / SPECIFIC EFFECTS AND SEVERITY].
Monitoring results: [LABS / VITALS WITH VALUES].

Plan: [CONTINUE / INCREASE TO DOSE / TAPER / STOP]. Reason: [REASON].
If dose change: discussed new dose, added risk [RISK], patient agrees to [PLAN] and asked [QUESTION OR NONE].
On-label alternatives revisited: [STILL NOT APPROPRIATE BECAUSE REASON / NOW CONSIDERING OPTION].
Next reassessment: [DATE].
[NP NAME], [CREDENTIALS]

When the patient declines

OFF-LABEL OPTION DECLINED
Date/time: [DATE] [TIME]
Offered [DRUG] [DOSE] for [CONDITION] (off label).
Discussed: off-label status, expected benefit [BENEFIT], risks [RISKS], alternatives [ALTERNATIVES], and no treatment.
Patient questions: [QUESTIONS AND ANSWERS].
Patient decision: declined. Reason given by patient: [REASON IN PATIENT'S WORDS].
Plan instead: [ALTERNATIVE PLAN OR WATCHFUL WAITING]. Patient informed the option remains open and may revisit at [DATE OR NEXT VISIT].
Referral/second opinion offered: [YES, TO WHOM / NOT REQUESTED].
[NP NAME], [CREDENTIALS]

Words to avoid

Word or phrase Why it hurts Use instead
pt agreesSays a yes happened. Leaves out what the yes was toPt chose to start [DRUG] after discussing [OPTIONS]
pt understandsThat's your conclusion, and there's no evidence under itThe patient's own restatement, or their questions and your answers
risks/benefits discussedNo content at allThe specific risks and benefits you named
standard off-label useClaims a standard and never shows oneThe guideline, trial, or reference you used
per protocolHides whether you individualized anythingThe patient-specific reason this drug fits
consent obtainedPoints to a signature. Says nothing about the conversationWhat was said, who was there, interpreter if used
failed medsWhich ones? How?Drug, dose, duration, and why it was stopped

Nobody reading the note can see the decision

The most common mistake is the one-liner: Off-label use discussed with pt, pt agrees. It feels complete, because the conversation really happened. On paper it says only that the topic came up. Nobody reading it can see the indication, what you weighed, what the patient was told, or whether they understood.

Second mistake: treating the signed form as the consent. Nurses in many threads describe the same setup. The RN witnesses the signature and the provider does the explaining. With an off-label prescription, the provider is you. The form proves a signature exists. Your note proves there was a conversation, and records what was said in it.

Third: the template that reads the same for every patient. Twenty patients, twenty notes, the same rationale sentence word for word. That record looks like habit. Nobody will see an individual decision in it.

Bottom line

Anyone who reads your note later should see three things: why you picked this drug, what you ruled out, and what the patient told you after hearing all of it.

Official guidance

In court, 2015–2020

What happened in 3 court cases

State v. Richard Z.: New York Supreme Court, 2017. The drug here was off label (Lupron, used as an antiandrogen), and the patient had been asking for it for years. The court looked hard at the consent conference. It ran about 30 minutes. The psychiatrist leading it had been reassigned to the case only days earlier and had no background in that treatment area. The court concluded the questioning had steered the patient's recorded answers. It also found that this patient was someone who "clearly understands the off-label use of this prescription and its risk." What it means for your charting: a court will read your record of a consent conversation to decide whether it was a real exchange. The patient's own questions and reasoning, written down, are what make that record believable.

Planned Parenthood of the Heartland, Inc. and Jill Meadows v. Iowa Board of Medicine: Supreme Court of Iowa, 2015. This one is mostly a constitutional challenge to a board rule, so it matters here only in a narrow way. The opinion describes an off-label dosing regimen that the specialty society accepted as the standard of care. It also describes what the prescriber does before giving the drug: the physician "informs the patient about the medication regime, potential complications, what to expect after ingesting the misoprostol, and answers questions the patient may have." Use that sentence as a checklist for your own note: regimen, complications, what to expect, the patient's questions. (The court later issued an amended version of the same opinion.)

United States v. Xiulu Ruan: Court of Appeals for the Eleventh Circuit, 2020. A criminal case against two pain physicians. The opinion says off-label prescribing of the drugs involved was not illegal. So the government went after the pattern. Most patients getting a drug approved for cancer pain didn't have cancer, and prescribing volume tracked the doctors' financial interests. A government expert testified that "prescribing drugs based on one’s own financial interest is outside the usual course of professional practice." The lesson for your chart: if nothing in it gives a patient-specific reason for the off-label choice, other evidence fills that gap. Nurse practitioners who had worked with the defendants testified at the trial.

Court decisions

Published decisions, linked to CourtListener.

All decisions behind this guide

From nurses online

Quoted as written. Opinion, not a source.

  • As an RN, you cannot legally explain the risks and benefits of surgeries interventions. Only provide education based on what the doctor provided. Think of it like prescribing, we don't prescribe without being trained as practitioners, an RNFA is a surgical first assistant and I dont even think

    r/nursing on Reddit: Signing consents reddit

  • Legal cleared it and it’s outlined in a written policy if there’s any issues. The physician does have to document in the note “risks and benefits of X procedure explained… informed consent obtained…”

    r/nursing on Reddit: I need your help… is this legal?? reddit

  • We have two advanced nurse practitioners in our paeds hame/onc unit that can prescribe certain drugs within their scope of practice and it makes life so much easier.

    r/nursing on Reddit: Nurse practitioner prescribing rights? reddit

  • Our policy is nurses can have the ... explain the informed consent but can get the signature. The patient can tell you and there should be a note in the chart that it was discussed....

    Question about consents… : r/nursing reddit

Other guides

Advice, not law.